Financhill
Back

Plus Therapeutics, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.

Plus Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.6 Buy
20-day SMA: 0.55 Buy
50-day SMA: 0.61 Buy
200-day SMA: 0.6 Buy
8-day EMA: 0.59 Buy
20-day EMA: 0.57 Buy
50-day EMA: 0.57 Buy
200-day EMA: 0.69 Sell

Plus Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 62.15 Buy
Chaikin Money Flow: 7734507 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.51 - 0.59) Buy
Bollinger Bands (100): (0.45 - 0.67) Buy

Plus Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Plus Therapeutics, Inc. Stock

Is Plus Therapeutics, Inc. Stock a Buy?

PSTV Technical Analysis vs Fundamental Analysis

Sell
46
Plus Therapeutics, Inc. (PSTV) is a Sell

Is Plus Therapeutics, Inc. a Buy or a Sell?

Plus Therapeutics, Inc. Stock Info

Market Cap:
90M
Price in USD:
0.66
Share Volume:
9.3M

Plus Therapeutics, Inc. 52-Week Range

52-Week High:
2.31
52-Week Low:
0.16
Sell
46
Plus Therapeutics, Inc. (PSTV) is a Sell

Plus Therapeutics, Inc. Share Price Forecast

Is Plus Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Plus Therapeutics, Inc.

Is Plus Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.84 per share, and an increase next year of $0.09 per share.

Technical Analysis of Plus Therapeutics, Inc.

Should I short Plus Therapeutics, Inc. stock?

* Plus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.